Traws Pharma Inc.
TRAW | NASDAQ
$0.49
-$0.05 (-8.50%)
Sep 18, 2026, 4:00 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 2.79M | 226K | 226K | 226K | 226K | 231K |
Cost of Revenue | n/a | 12K | n/a | n/a | n/a | n/a |
Gross Profit | 2.79M | 214K | 226K | 226K | 226K | 231K |
Operating Income | -17.88M | -49.35M | -20.3M | -19.63M | -16.5M | -24.99M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 9.17M | -166.52M | -18.95M | -18.96M | -16.16M | -25.15M |
Net Income | 9.17M | -54.67M | -18.95M | -18.96M | -16.16M | -25.16M |
Selling & General & Admin | 8.52M | 12.29M | 9.09M | 8.45M | 9.43M | 8.33M |
Research & Development | 12.14M | 130.31M | 11.43M | 11.41M | 7.3M | 16.9M |
Other Expenses | n/a | -93.04M | n/a | n/a | n/a | n/a |
Operating Expenses | 20.67M | 49.56M | 20.52M | 19.85M | 16.72M | 25.22M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 20.67M | 49.57M | 20.52M | 19.85M | 16.72M | 25.22M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | 4K |
Shares Outstanding (Basic) | 8.23M | 1.55M | 839.55K | 836.33K | 673.29K | 464.1K |
Shares Outstanding (Diluted) | 8.38M | 1.55M | 839.55K | 836.33K | 673.29K | 464.1K |
EPS (Basic) | 0.83 | -35.21 | -22.57 | -22.68 | -24.01 | -54.21 |
EPS (Diluted) | 0.82 | -35.21 | -22.57 | -22.68 | -24.01 | -54.21 |
EBITDA | -17.81M | -166.51M | -20.28M | -19.61M | -16.48M | -24.98M |
EBIT | -17.88M | -166.52M | -20.3M | -19.63M | -16.5M | -24.99M |
Depreciation & Amortization | 61K | 12K | 16K | 14K | 14K | 13K |
Add to Watchlist
Select watchlists to add or remove TRAW